SynthesisAnnals of the rheumatic diseases2002

Adalimumab (a fully human anti-tumour necrosis factor alpha monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials.

R RauPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.